These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35627340)

  • 1. Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?
    Stefańczyk P; Nowosielecka D; Polewczyk A; Tułecki Ł; Tomków K; Jacheć W; Lewicka E; Tomaszewski A; Kutarski A
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Long-Term Survival of Octogenarians and Nonagenarians Undergoing Transvenous Lead Extraction Procedures.
    Jacheć W; Polewczyk A; Segreti L; Bongiorni MG; Kutarski A
    Gerontology; 2021; 67(1):36-48. PubMed ID: 33242867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High recurrence of device-related adverse events following transvenous lead extraction procedure in patients with cardiac resynchronization devices.
    Regoli F; Bongiorni MG; Rordorf R; Santamaria M; Klersy C; Segreti L; De Regibus V; Moccetti T; Conte G; Caputo ML; Auricchio A
    Eur J Heart Fail; 2016 Oct; 18(10):1270-1277. PubMed ID: 27170594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Transvenous Lead Extraction at the Time of Upgrade from Pacemakers to Cardioverter-Defibrillators and Cardiac Resynchronization Therapy.
    Stefańczyk P; Nowosielecka D; Polewczyk A; Jacheć W; Głowniak A; Kosior J; Kutarski A
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.
    Gould J; Klis M; Porter B; Sieniewicz BJ; Sidhu BS; Claridge S; Williams SE; Shetty A; O'Neill M; Gill J; Rinaldi CA
    Europace; 2019 Jun; 21(6):928-936. PubMed ID: 30590509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead extraction: The road to successful cardiac resynchronization therapy.
    Maciąg A; Syska P; Sterliński M; Przybylski A; Sitkowska E; Oręziak A; Bilińska M; Kuśmierczyk M; Szwed H
    Cardiol J; 2015; 22(2):188-93. PubMed ID: 25299498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.
    Hayashi K; Callahan T; Rickard J; Baranowski B; Martin DO; Nakhla S; Tabaja C; Paul A; Wilkoff BL
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1382-1392. PubMed ID: 38725252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same-day discharge after transvenous lead extraction: feasibility and outcomes.
    Atteya G; Alston M; Sweat A; Saleh M; Beldner S; Mitra R; Willner J; John RM; Epstein LM
    Europace; 2023 Feb; 25(2):586-590. PubMed ID: 36575941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of anticoagulation therapy on outcomes in patients with cardiac implantable resynchronization devices undergoing transvenous lead extraction: A substudy of the ESC-EHRA EORP ELECTRa (European Lead Extraction ConTRolled) Registry.
    Regoli F; Auricchio A; Di Cori A; Segreti L; Blomström-Lunqvist C; Butter C; Deharo JC; Kennergren C; Kutarski A; Laroche C; Zalevskiy V; Luzzi G; Cano O; Grabowski M; Rinaldi C; Bongiorni MG
    J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1086-1095. PubMed ID: 30980441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.
    Ząbek A; Boczar K; Ulman M; Holcman K; Kostkiewicz M; Pfitzner R; Dębski M; Musiał R; Lelakowski J; Małecka B
    Europace; 2023 Mar; 25(3):1100-1109. PubMed ID: 36660771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of incomplete coronary sinus lead removal during transvenous lead extraction in patients with cardiac resynchronization therapy.
    Hayashi K; Younis A; Callahan T; Baranowski B; Martin DO; Nakhla S; Wilkoff BL
    Heart Rhythm; 2023 Jun; 20(6):872-878. PubMed ID: 36933853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.
    Segreti L; Rinaldi CA; Claridge S; Svendsen JH; Blomstrom-Lundqvist C; Auricchio A; Butter C; Dagres N; Deharo JC; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Kempa M; Magnani A; Casteigt B; Bongiorni MG;
    Europace; 2019 Apr; 21(4):645-654. PubMed ID: 30624715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ICD lead on the system durability, predictors of long-term survival following ICD system extraction.
    Jacheć W; Tomasik A; Polewczyk A; Kutarski A
    Pacing Clin Electrophysiol; 2017 Oct; 40(10):1139-1146. PubMed ID: 28846144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in transvenous lead extraction in young adults.
    Kutarski A; Jacheć W; Tułecki Ł; Czajkowski M; Nowosielecka D; Stefańczyk P; Tomków K; Polewczyk A
    Sci Rep; 2022 Jun; 12(1):9601. PubMed ID: 35689031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of transvenous extraction of single- versus dual-coil implantable cardioverter-defibrillator leads at single-center experience.
    Ząbek A; Boczar K; Dębski M; Ulman M; Pfitzner R; Musiał R; Lelakowski J; Małecka B
    Medicine (Baltimore); 2019 Jul; 98(30):e16548. PubMed ID: 31348275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.
    Chung DU; Tauber J; Kaiser L; Schlichting A; Pecha S; Sinning C; Rexha E; Reichenspurner H; Willems S; Gosau N; Hakmi S
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):247-257. PubMed ID: 33377195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.
    Hayashi K; Callahan T; Rickard J; Younis A; Baranowski B; Martin D; Nakhla S; Tabaja C; Wilkoff BL
    Europace; 2023 Dec; 25(12):. PubMed ID: 38000893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
    Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.